
South Africa
In KwaZulu-Natal province, our project’s community-oriented approach is to increase integrated HIV testing and TB screening, as well as access and adherence to HIV treatment.
The Khayelitsha project near Cape Town continues to develop and implement treatment regimens for MDR-TB and innovative models of care for patients living with HIV and TB.
Our teams are currently responding to the coronavirus COVID-19 pandemic in South Africa.
Our activities in 2020 in South Africa
Data and information from the International Activity Report 2020.
254
254
€12 M
12M
1999
1999


18,400
18,4
340
34
320
32

240
24

More MSF patients with DR-TB gain access to dramatically cheaper version of life-saving drug
Clinical Mentorship of Nurse Initiated Antiretroviral Therapy in Khayelitsha, South Africa: A Quality of Care Assessment

"This disease is for heroes. If you can fight this, you can stand anything in this world"

The old devil in new clothes
Outcomes in Adolescents Undergoing Treatment for Drug-Resistant Tuberculosis in Cape Town, South Africa, 2008-2013

Two new studies point to impact of HIV treatment on transmission in high-HIV-burden African contexts
Reflections on a decade of delivering PMTCT in Khayelitsha, South Africa
Clinical Access to Bedaquiline Programme for the treatment of drug-resistant tuberculosis

MSF calls for scale-up of ‘viral load’ monitoring to improve HIV treatment outcomes in developing countries
Contact us

7th Floor, Zurich House
70 Fox Street, Marshalltown
Johannesburg
South Africa